Pay for performance program reduces treatment needed diabetic retinopathy - A nationwide matched cohort study in Taiwan

Shwu Jiuan Sheu, Wen Liang Lin, Yea-Huei Kao, Chi Min Hwu, Ching-Lan Cheng

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to determine the effect of pay-for-performance program on the development of treatment needed for diabetic retinopathy in type 2 diabetes patients. Methods: We conducted a nationwide retrospective cohort study with a matching design using the Taiwan National Health Insurance Research Database from 2000 to 2012. The outcome was defined as the treatment needed diabetic retinopathy. We matched Pay-for-Performance and non-Pay-for-Performance groups for age, gender, year diabetes was diagnosed and study enrollment, and duration of follow-up. Results: A total of 9311 patients entered the study cohort, of whom 2157 were registered in the Pay-for-Performance group and 7154 matched in the non-Pay-for-Performance group. The incidence of treatment needed diabetic retinopathy was not significantly different in two groups. However, the incidence of treatment needed diabetic retinopathy was significantly different if restricted the non-Pay-for-Performance group who had at least 1 eye examination or optical coherence tomography within 1 year (adjusted hazard ratio, 0.78; 95% confidence interval, 0.64-0.94). Conclusions: Pay-for-Performance is valuable in preventing the development of treatment needed diabetic retinopathy, which could be attributed to the routine eye examination required in the Pay-for-Performance program. We could improve our diabetic care by promoting eye health education and patient awareness on the importance of regular examinations.

Original languageEnglish
Article number638
JournalBMC Health Services Research
Volume18
Issue number1
DOIs
Publication statusPublished - 2018 Aug 15

Fingerprint

Incentive Reimbursement
Diabetic Retinopathy
Taiwan
Cohort Studies
Therapeutics
Incidence
Optical Coherence Tomography
National Health Programs
Patient Education
Health Education
Type 2 Diabetes Mellitus
Research Design
Retrospective Studies
Age Groups
Databases
Confidence Intervals
Research

All Science Journal Classification (ASJC) codes

  • Health Policy

Cite this

@article{7d5cd0f7c87a4a37af7ecace646fea51,
title = "Pay for performance program reduces treatment needed diabetic retinopathy - A nationwide matched cohort study in Taiwan",
abstract = "Background: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to determine the effect of pay-for-performance program on the development of treatment needed for diabetic retinopathy in type 2 diabetes patients. Methods: We conducted a nationwide retrospective cohort study with a matching design using the Taiwan National Health Insurance Research Database from 2000 to 2012. The outcome was defined as the treatment needed diabetic retinopathy. We matched Pay-for-Performance and non-Pay-for-Performance groups for age, gender, year diabetes was diagnosed and study enrollment, and duration of follow-up. Results: A total of 9311 patients entered the study cohort, of whom 2157 were registered in the Pay-for-Performance group and 7154 matched in the non-Pay-for-Performance group. The incidence of treatment needed diabetic retinopathy was not significantly different in two groups. However, the incidence of treatment needed diabetic retinopathy was significantly different if restricted the non-Pay-for-Performance group who had at least 1 eye examination or optical coherence tomography within 1 year (adjusted hazard ratio, 0.78; 95{\%} confidence interval, 0.64-0.94). Conclusions: Pay-for-Performance is valuable in preventing the development of treatment needed diabetic retinopathy, which could be attributed to the routine eye examination required in the Pay-for-Performance program. We could improve our diabetic care by promoting eye health education and patient awareness on the importance of regular examinations.",
author = "Sheu, {Shwu Jiuan} and Lin, {Wen Liang} and Yea-Huei Kao and Hwu, {Chi Min} and Ching-Lan Cheng",
year = "2018",
month = "8",
day = "15",
doi = "10.1186/s12913-018-3454-6",
language = "English",
volume = "18",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",
number = "1",

}

Pay for performance program reduces treatment needed diabetic retinopathy - A nationwide matched cohort study in Taiwan. / Sheu, Shwu Jiuan; Lin, Wen Liang; Kao, Yea-Huei; Hwu, Chi Min; Cheng, Ching-Lan.

In: BMC Health Services Research, Vol. 18, No. 1, 638, 15.08.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pay for performance program reduces treatment needed diabetic retinopathy - A nationwide matched cohort study in Taiwan

AU - Sheu, Shwu Jiuan

AU - Lin, Wen Liang

AU - Kao, Yea-Huei

AU - Hwu, Chi Min

AU - Cheng, Ching-Lan

PY - 2018/8/15

Y1 - 2018/8/15

N2 - Background: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to determine the effect of pay-for-performance program on the development of treatment needed for diabetic retinopathy in type 2 diabetes patients. Methods: We conducted a nationwide retrospective cohort study with a matching design using the Taiwan National Health Insurance Research Database from 2000 to 2012. The outcome was defined as the treatment needed diabetic retinopathy. We matched Pay-for-Performance and non-Pay-for-Performance groups for age, gender, year diabetes was diagnosed and study enrollment, and duration of follow-up. Results: A total of 9311 patients entered the study cohort, of whom 2157 were registered in the Pay-for-Performance group and 7154 matched in the non-Pay-for-Performance group. The incidence of treatment needed diabetic retinopathy was not significantly different in two groups. However, the incidence of treatment needed diabetic retinopathy was significantly different if restricted the non-Pay-for-Performance group who had at least 1 eye examination or optical coherence tomography within 1 year (adjusted hazard ratio, 0.78; 95% confidence interval, 0.64-0.94). Conclusions: Pay-for-Performance is valuable in preventing the development of treatment needed diabetic retinopathy, which could be attributed to the routine eye examination required in the Pay-for-Performance program. We could improve our diabetic care by promoting eye health education and patient awareness on the importance of regular examinations.

AB - Background: Pay-for-Performance programs have shown improvement in indicators monitoring adequacy and target achievement in diabetic care. However, less is known regarding the impact of this program on the occurrence and long-term effects of diabetic retinopathy. The objective of this study was to determine the effect of pay-for-performance program on the development of treatment needed for diabetic retinopathy in type 2 diabetes patients. Methods: We conducted a nationwide retrospective cohort study with a matching design using the Taiwan National Health Insurance Research Database from 2000 to 2012. The outcome was defined as the treatment needed diabetic retinopathy. We matched Pay-for-Performance and non-Pay-for-Performance groups for age, gender, year diabetes was diagnosed and study enrollment, and duration of follow-up. Results: A total of 9311 patients entered the study cohort, of whom 2157 were registered in the Pay-for-Performance group and 7154 matched in the non-Pay-for-Performance group. The incidence of treatment needed diabetic retinopathy was not significantly different in two groups. However, the incidence of treatment needed diabetic retinopathy was significantly different if restricted the non-Pay-for-Performance group who had at least 1 eye examination or optical coherence tomography within 1 year (adjusted hazard ratio, 0.78; 95% confidence interval, 0.64-0.94). Conclusions: Pay-for-Performance is valuable in preventing the development of treatment needed diabetic retinopathy, which could be attributed to the routine eye examination required in the Pay-for-Performance program. We could improve our diabetic care by promoting eye health education and patient awareness on the importance of regular examinations.

UR - http://www.scopus.com/inward/record.url?scp=85051483542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051483542&partnerID=8YFLogxK

U2 - 10.1186/s12913-018-3454-6

DO - 10.1186/s12913-018-3454-6

M3 - Article

C2 - 30111370

AN - SCOPUS:85051483542

VL - 18

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 638

ER -